Gabardi S, Martin S, Sura M, Mohammed A, Golan Y. Micafungin treatment and eradication of candiduria among hospitalized patients. Int Urol Nephrol 2016;48(11):1881-5. https://www.ncbi.nlm.nih.gov/pubmed/27587066
Keighley C, Cooley L, Morris AJ, Ritchie D, Clark JE, Boan P, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J 2021;51 Suppl 7:89-117. https://www.ncbi.nlm.nih.gov/pubmed/34937142
Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 2016;62(4):e1-50. https://www.ncbi.nlm.nih.gov/pubmed/26679628
Rkieh L, El Nekidy WS, Alsoud LO, Alatoom A, El Lababidi R, Mooty M, et al. Outcomes of caspofungin use in the treatment of Candida-related urinary tract infections, a case series. IDCases 2022;28:e01510. https://www.ncbi.nlm.nih.gov/pubmed/35646592
Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 2000;46(2):171-9. https://www.ncbi.nlm.nih.gov/pubmed/10933638
